NIH grant program investigates COVID-19's impact on underserved and vulnerable populations
The National Institutes of Health is offering several grants to increase research into the growing body of evidence suggesting that underserved and/or vulnerable populations are more susceptible to COVID-19 infection, severe complications and associated death, as well as to the pandemic's social, behavioral and economic impacts. Through NIH's National Institute on Minority Health and Health Disparities, the following grant opportunities are being made available:
- Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
- Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
- RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
- Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Related News Articles
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…